Wijziging van de Geneesmiddelenwet ter implementatie van richtlijn 2011/62/EU om te verhinderen dat vervalste geneesmiddelen in de legale distributieketen belanden

This procedure is a motion to amend the Dutch Medicines Act to implement EU Directive 2011/62/EU. The primary goal is to strengthen the safety of the pharmaceutical supply chain by preventing counterfeit or falsified medicines from entering the legal distribution network. This affects pharmaceutical distributors and healthcare providers in the Netherlands, ensuring patients receive authentic medications and reducing the risk of health hazards caused by fraudulent drugs.